logo
  

BD Aims To Reduce GHG Emissions 46% By 2030

Medical technology company BD (Becton, Dickinson and Company) (BDX) announced a new strategy to advance environmental, social and governance (ESG) initiatives, as well as a suite of goals for 2030 and beyond.

The company aims to reduce Scope 1 and 2 greenhouse gas (GHG) emissions 46% by 2030 (from a 2019 baseline) and achieve carbon neutrality across direct operations by 2040. The company also committed to set targets to reduce Scope 3 emissions.

The company also aims to reduce the environmental impact of the company's product portfolio by addressing plastic and packaging material consumption and the impact of plastics throughout its value chain through considerations in product design; and reduce Scope 3 emissions from use and disposal of products in line with 1.5°C emissions scenarios.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration approved Regeneron Pharmaceuticals, Inc.'s Dupixent (dupilumab) to treat eosinophilic esophagitis or EoE, a chronic immune disorder. It is the first FDA approval to treat EoE in adults and pediatric patients 12 years and older weighing at least 40 kilograms. Food products maker J. M. Smucker Co. has recalled select Jif peanut butter products sold in the United States due to potential Salmonella contamination, the U.S. Food and Drug Administration said. The recall involves various creamy, crunchy, natural, no added sugar, and reduced fat peanut butter, among others with lot codes 1274425 - 2140425. Smithfield Packaged Meats Corp. is recalling around 185,610 pounds of ready-to-eat or RTE bacon topping products citing the possible contamination with extraneous materials, specifically metal, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced.
Follow RTT